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Background: Transcatheter Aortic Valve Implantation (TAVI) is an emerging treatment for patients with severe aortic stenosis (AS) deemed 
unsuitable for conventional aortic valve surgery. Accurate multimodality imaging is mandated for patient assessment and procedural guidance. We 
describe our experience of 3D transesophageal echo (TEE) in a large cohort of TAVIs.
Methods: All patients referred for TAVI had 2D transthoracic echo to assess anatomic suitability. If there was any uncertainty following this, a TEE 
was performed. In addition all patients underwent 2D and 3D TEE during the TAVI procedure.
Results: Between August 2007 and September 2009, 150 patients (mean age 82.6 +/-7.3 years) with severe AS (peak gradient 79.4 +/-23.8 
mmHg, mean 48.9 +/-15.3, calculated valve area 0.6 +/-0.16 cm2) underwent either transapical (56%) or transfemoral TAVI, in our institution. All 
procedures were performed in the cardiac catheter laboratory and procedural success was achieved in 98%. In all patients adequate 2D and 3D 
images were possible. 3D imaging was used to provide anatomically correct information regarding the morphology of the aortic valve annulus and 
surrounding structures. 3D TEE provided superior visualisation (over 2D) of guide wire and catheter placement, device positioning and deployment. 
It also provided additional information for real time monitoring of complications. Immediately post deployment 82% of patients had either no or 
trace paravalvular regurgitation; 14% had mild, 4% moderate and none severe. Transvalvular regurgitation was present in 41% (35% trace, 5% mild, 
0% moderate and 1% severe). There were no cases of coronary ostial occlusion. Upward migration of the device during deployment was seen in two 
cases. Post procedure echo peak and mean gradients fell to 10.6 +/-0.5 and 5.3 +/-0.3mmHg respectively (p<0.005 for both when compared to 
baseline).
Conclusions: In this large series, 3D TEE appears uniquely placed to provide detailed anatomical information, spatial orientation and continuous 
real-time imaging during TAVI. We believe the additional information provided by 3D imaging aids patient assessment, facilitates the procedure and 
may contribute to favourable outcomes
